Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZHB206
- Development stage
- Phase 2
- Lead developer
- Changzhou Qianhong Biopharma
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
ZHB206 is a recombinant humanized anti-glycoprotein VI (GPVI) antibody fragment (Fab) being developed for the treatment of acute ischemic stroke (AIS). GPVI is a platelet-specific collagen receptor that plays a critical role in the initiation of arterial thrombosis. By blocking the binding of GPVI to exposed subendothelial collagen, ZHB206 inhibits platelet activation and thrombus growth. A key therapeutic advantage of targeting GPVI is the potential to decouple antithrombotic efficacy from bleeding risk, as GPVI deficiency in humans does not lead to severe bleeding diathesis. The drug is currently undergoing clinical evaluation in China by Changzhou Qianhong Bio-pharma and its research arm, Jiangsu Zhonghong Biopharmaceutical Institute.
- Other names
- Recombinant humanized anti-GPVI antibody fragment
02
Targets
GPVI (Platelet glycoprotein VI)
Beyond the preview
Go deeper on ZHB206.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZHB206.